EU Policies & Directives

  • Social Health Protection

    Despite considerable attention over many decades, striking inequalities among and within countries still exist. Several social factors that can influence health can be found in the image below. The Social…

    Read More »
  • Orphan Drugs

    An orphan medicinal product is one that is intended for the diagnosis, prevention or treatment of a condition that affects not more than 5 in 10 000 persons, according to…

    Read More »
  • Rare Diseases

    Rare diseases, including those of genetic origin, are life-threatening or chronically debilitating diseases which are of such low prevalence that special combined efforts are needed to address them. As a…

    Read More »
  • Cross-Border Healthcare

    The Directive 2011/24/EU, clarifies that EU patients seeking healthcare outside their country may do so as long as the type of treatment would have been normally provided at home. Payment…

    Read More »
  • Clinical Trials

    Why Participate in a Clinical Trial? There are many reasons why people choose to join a clinical trial. Some join a trial because the treatments they have tried for their health…

    Read More »
  • Pharmacovigilance

    It is a well known fact that little is truly known about any medicinal product prior to its entry into the market and interaction with a more diverse population than…

    Read More »
  • Patient Safety

    Every year, millions of patients suffer injuries or die because of unsafe and poor-quality health care. Many medical practices and risks associated with health care are emerging as major challenges…

    Read More »
  • Blood Safety & Availability

    Blood Availability Great variability exists regarding availability of blood and blood donation practices among countries, influenced by socioeconomical factors. In high-income countries, blood collection tends to be a well-established practice…

    Read More »
Back to top button